ElevateSells LogoElevateSells
Back to Companies Directory
VERIFIED COMPANY DOSSIER

Oblique Therapeutics AB (publ.)

Verified Intel

Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.

obliquet.comLinkedIn

Oblique Therapeutics AB (publ.) is a Swedish biotech company developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and advanced cancer. The company uses Abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.

Primary SectorGeneral Industry
Workforce Size11-50 Employees
Global HQUndisclosed, Sweden
Total Capital RaisedBootstrapped / Private

Corporate Firmographics

Entity classification and operating profile

Industry
General
Company Type
Public Company
Founded
2015
Employee Bracket
11-50
Estimated Revenue Range
Undisclosed

Geographic Coordinates

Headquarters address and regional territory

Street Address
Arvid Wallgrens Backe 20 Västra Götalands Län Göteborg
City
—
Region / State
—
Postal Code
413 46
Country
Sweden

Digital Presence & Footprint

Verified domains, socials, and directory profiles

Official Domainobliquet.com
Visit Site
LinkedIn NetworkActive Profile
Open LinkedIn
OUTREACH AUTOMATION

Target Decision-Makers at Oblique Therapeutics AB (publ.)

Connect your mailboxes, set up your autonomous SDR Agent, and start generating hyper-personalized pipeline for accounts like Oblique Therapeutics AB (publ.) in minutes.

SYNTHESIZED INTEL

Frequently Asked Questions

Verified business inquiries and firmographic telemetry for Oblique Therapeutics AB (publ.).